Patents by Inventor David W. Robertson

David W. Robertson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Inotropic agents
    Patent number: 4617302
    Abstract: This invention provides certain pyridazinone derivatives, their pharmaceutical formulations, and their use as positive inotropic agents.
    Type: Grant
    Filed: October 15, 1984
    Date of Patent: October 14, 1986
    Assignee: Eli Lilly and Company
    Inventor: David W. Robertson
  • Pyridazinone derivatives as inotropic agents
    Patent number: 4591591
    Abstract: This invention provides for the use of certain pyridazinones as positive inotropic agents.
    Type: Grant
    Filed: March 8, 1984
    Date of Patent: May 27, 1986
    Assignee: Eli Lilly and Company
    Inventor: David W. Robertson
  • Anti-convulsant fluorenylalkylimidazole derivatives, compositions, and method of use
    Patent number: 4533670
    Abstract: This invention provides for certain fluorenylalkyl imidazoles and their pharmaceutical formulations and their use as anticonvulsant agents.
    Type: Grant
    Filed: September 21, 1983
    Date of Patent: August 6, 1985
    Assignee: Eli Lilly and Company
    Inventor: David W. Robertson
  • Inotropic agents
    Patent number: 4533734
    Abstract: This invention provides for certain imidazo compounds, their pharmaceutical formulations, and their use as positive inotropic agents, bronchodilators, vasodilators, and anticoagulants.
    Type: Grant
    Filed: November 10, 1983
    Date of Patent: August 6, 1985
    Assignee: Eli Lilly and Company
    Inventor: David W. Robertson
  • Certain naphthalenyl imidazo compounds and their pharmaceutical use
    Patent number: 4515796
    Abstract: This invention provides for certain naphthalenylimidazo compounds, their pharmaceutical formulations, and their use as positive inotropic agents, bronchodilators, vasodilators, and anticoagulants.
    Type: Grant
    Filed: September 8, 1983
    Date of Patent: May 7, 1985
    Assignee: Eli Lilly and Company
    Inventor: David W. Robertson